1. Home
  2. HBNC vs RAPP Comparison

HBNC vs RAPP Comparison

Compare HBNC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBNC
  • RAPP
  • Stock Information
  • Founded
  • HBNC 1873
  • RAPP 2022
  • Country
  • HBNC United States
  • RAPP United States
  • Employees
  • HBNC N/A
  • RAPP N/A
  • Industry
  • HBNC Major Banks
  • RAPP
  • Sector
  • HBNC Finance
  • RAPP
  • Exchange
  • HBNC Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • HBNC 809.8M
  • RAPP 844.6M
  • IPO Year
  • HBNC N/A
  • RAPP 2024
  • Fundamental
  • Price
  • HBNC $16.98
  • RAPP $19.74
  • Analyst Decision
  • HBNC Hold
  • RAPP Strong Buy
  • Analyst Count
  • HBNC 3
  • RAPP 4
  • Target Price
  • HBNC $16.33
  • RAPP $37.33
  • AVG Volume (30 Days)
  • HBNC 157.1K
  • RAPP 124.8K
  • Earning Date
  • HBNC 01-22-2025
  • RAPP 02-10-2025
  • Dividend Yield
  • HBNC 3.60%
  • RAPP N/A
  • EPS Growth
  • HBNC N/A
  • RAPP N/A
  • EPS
  • HBNC 0.48
  • RAPP N/A
  • Revenue
  • HBNC $183,718,000.00
  • RAPP N/A
  • Revenue This Year
  • HBNC N/A
  • RAPP N/A
  • Revenue Next Year
  • HBNC $13.76
  • RAPP N/A
  • P/E Ratio
  • HBNC $36.80
  • RAPP N/A
  • Revenue Growth
  • HBNC N/A
  • RAPP N/A
  • 52 Week Low
  • HBNC $11.18
  • RAPP $16.55
  • 52 Week High
  • HBNC $19.18
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • HBNC 46.33
  • RAPP N/A
  • Support Level
  • HBNC $17.26
  • RAPP N/A
  • Resistance Level
  • HBNC $17.95
  • RAPP N/A
  • Average True Range (ATR)
  • HBNC 0.42
  • RAPP 0.00
  • MACD
  • HBNC -0.15
  • RAPP 0.00
  • Stochastic Oscillator
  • HBNC 16.08
  • RAPP 0.00

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: